US Bancorp’s Ventyx Biosciences VTYX Stock Holding History

US Bancorp’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,790	Closed	-$52.3K	–	4348
2025 Q4	$52.3K	Buy	+5,790	New	+$43.3K	﹤0.01%	2679
2023 Q4	–	Sell	-5,357	Closed	-$186K	–	4164
2023 Q3	$186K	Sell	5,357 -765	-12%	-$26.4K	﹤0.01%	1862
2023 Q2	$201K	Sell	6,122 -775	-11%	-$26.7K	﹤0.01%	1859
2023 Q1	$231K	Sell	6,897 -7,302	-51%	-$284K	﹤0.01%	1792
2022 Q4	$466K	Buy	+14,199	New	+$421K	﹤0.01%	1434

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

US Bancorp's VTYX Position: Q1 2026 in Review

US Bancorp sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 5,790 shares — an estimated $52.3K sold.

US Bancorp first reported a position in VTYX in Q4 2022 and held it in 5 quarters. The position peaked at $466K in Q4 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

US Bancorp reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
US Bancorp sold 5,790 Ventyx Biosciences shares in Q1 2026, an estimated $52.3K.
US Bancorp first reported a position in Ventyx Biosciences in Q4 2022 and held it in 5 quarters.
US Bancorp's Ventyx Biosciences position peaked at $466K in Q4 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.